NDAURETHRALSUPPOSITORYPriority Review
Approved
Nov 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
11
Data completeness
4/8 — Partial
Priority Review
MUSE (alprostadil) by Viatris is prostaglandin receptor agonists [moa]. First approved in 1996.
Drug data last refreshed 10h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MUSE (alprostadil) is a prostaglandin receptor agonist administered as a urethral suppository for the treatment of erectile dysfunction. It works by relaxing smooth muscle and dilating blood vessels in the penis to facilitate erection. The product represents one of the first non-injection, non-oral treatments for ED.
LOE Approaching
As LOE approaches, the brand faces moderate competitive pressure (30/100) with a lean 3-linked job count, signaling a stable but contracting team focused on defense and managed decline.
Mechanism of Action
Prostaglandin Receptor Agonists
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (11)
Use of Inertial Units in Patient With Multiple Sclerosis (IMUSEP)
Started Nov 2024
70 enrolled
Multiple SclerosisMedical DeviceCoordination and Balance Disturbances
Modern Urodynamics System Efficacy (MUSE) Study
Started Aug 2023
38 enrolled
Urologic DiseasesUrodynamics
Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot
Started Nov 2022
60 enrolled
Tetralogy of FallotVentricular TachycardiaSudden Cardiac Death
Meditation Utilizing Signals From Electroencephalography in Chronic Pain (MUSE-PAIN) Study
Started Jul 2021
50 enrolled
Chronic Pain
ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer
Started Feb 2020
14 enrolled
Advanced Solid Tumors (Excluding Prostate Cancer)Ovarian Cancer
Worked on MUSE at Viatris? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.